Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3FW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,152
Award facts
- Contract value 100% obligated
- $25,151.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,151.85 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on January 12, 2026. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award utilizes no set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal government agencies, particularly supporting military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The contract vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. The current award for Zepbound, a diabetes medication, exemplifies the contractor's ongoing role in fulfilling essential pharmaceutical requirements for federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FG3FW?
SPE2DR26FG3FW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FG3FW worth?
The government has obligated $25,152 on SPE2DR26FG3FW.
Is contract SPE2DR26FG3FW an order under another contract?
Yes. SPE2DR26FG3FW is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3FW competed?
The extent of competition for SPE2DR26FG3FW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award